Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Mitsubishi Tanabe to Acquire Israeli-Based NeuroDerm for $1.1 Billion

Filed Under: Pharma Tagged With: , , , , , , ,

Mitsubishi Tanabe Pharma Corp. (TYO:4508) announced an agreement on July 24 to acquire Israeli-based NeuroDerm Ltd. for about $1.1 billion,…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Mitsubishi Chemical Holdings to Turn Mitsubishi Tanabe Pharma Into Wholly Owned Subsidiary
Mitsubishi Chemical Holdings to Turn Mitsubishi Tanabe…
Chemical and Material Companies Look to Take Pharmaceutical Operations to the Next Stage
Chemical and Material Companies Look to Take Pharmaceutical…
Japan’s Leading Drug Manufacturers Grow Sales Revenue on Back of Mainstay Products
Japan’s Leading Drug Manufacturers Grow Sales Revenue on…
Interview: Mitsubishi Chemical Holdings President Hitoshi Ochi Discusses Plans for 2020 and Beyond
Interview: Mitsubishi Chemical Holdings President Hitoshi…
Mitsubishi Chemical Holdings Reconsiders Holding Company Management, Looks to Fully Integrate Operating Subsidiaries
Mitsubishi Chemical Holdings Reconsiders Holding Company…
Fujifilm, JSR Stand out Among Major Chemical–Material Manufacturers in Health Care-Related Operations for First Half
Fujifilm, JSR Stand out Among Major Chemical–Material…